Emcure Pharmaceuticals Limited — Amikacin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Amikacin · $1.0M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #4 Indian exporter of Amikacin with $1.0M in export value and 16 verified shipments. Emcure Pharmaceuticals Limited holds a 3.8% market share in Amikacin exports across 3 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Amikacin Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Amikacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $553.8K | 13 | 65.9% |
| CANADA | $211.9K | 5 | 25.2% |
| MALTA | $74.6K | 2 | 8.9% |
Emcure Pharmaceuticals Limited exports Amikacin to 3 countries. The largest destination is UNITED KINGDOM accounting for 65.9% of Emcure Pharmaceuticals Limited's Amikacin shipments, followed by CANADA (25.2%) and MALTA (8.9%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Amikacin from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TILLOMED LABORATORIES LTD | UNITED KINGDOM | $453.8K | 11 |
| MARCAN PHARMACEUTICALS INC | CANADA | $100.0K | 2 |
| MARCAN PHARMACEUTICALS INC., | CANADA | $81.1K | 2 |
| TILLOMED LABORATORIES LIMITED | UNITED KINGDOM | $50.0K | 1 |
| TILLOMED LABORATORIES LTD ,,, | UNITED KINGDOM | $50.0K | 1 |
| TILLOMED MALTA LTD | MALTA | $45.4K | 1 |
| MARCAN PHARMACEUTICALS INC. | CANADA | $30.8K | 1 |
| TILLOMED MALTA LIMITED | MALTA | $29.2K | 1 |
Emcure Pharmaceuticals Limited supplies Amikacin to 8 buyers globally. The largest buyer is TILLOMED LABORATORIES LTD (UNITED KINGDOM), followed by MARCAN PHARMACEUTICALS INC (CANADA) and MARCAN PHARMACEUTICALS INC., (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Amikacin Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $9.5M worth of Amikacin through 1,657 shipments from 327 suppliers to 104 countries, serving 514 buyers globally. Emcure Pharmaceuticals Limited contributes $1.0M to this total, accounting for 3.8% of India's Amikacin exports. Emcure Pharmaceuticals Limited ships Amikacin to 3 countries through 8 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Amikacin Exports?
Emcure Pharmaceuticals Limited's average Amikacin shipment value is $62.5K per consignment, based on 16 shipments totaling $1.0M. The largest destination is UNITED KINGDOM (65.9% of Emcure Pharmaceuticals Limited's Amikacin exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Amikacin Exporters?
Emcure Pharmaceuticals Limited ranks #4 among 327 Indian Amikacin exporters with a 3.8% market share. The top 3 exporters are AVET LIFESCIENCES PRIVATE LIMITED ($2.4M), AJANTA PHARMA LIMITED ($1.4M), SCOTT EDIL PHARMACIA LIMITED ($875.1K). Emcure Pharmaceuticals Limited processed 16 shipments to 3 destination countries.
What Amikacin Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMIKACIN SULFATE INJ 500MG/2ML MA CA SN | $161.9K | 4 |
| MEDICINES AMIKACIN SULFATE INJ 500MG/2MLTILLO UK SN BATCH NO. ES230150A MANUFACTURING Jul 2023 EXP Jun 2025 | $150.0K | 3 |
| MEDICINES AMIKACIN SULFATE INJ 500MG/2ML | $50.0K | 1 |
| MEDICINES AMIKACIN SULFATE INJ 500MG/2MLTILLO UK SN BATCH NO ES230170B MANUFACTURING Aug 2023 EXP Jul 2025 | $50.0K | 1 |
| MEDICINES AMIKACIN SULFATE INJECTION 500MG/2ML TILLOMED UK SN : BATCH NO. ES240033A MFG: FEB 2024 EXP | $50.0K | 1 |
| MEDICINES AMIKACIN SULFATE INJECTION 500MG/2ML TILLOMED UK SN : BATCH NO. ES240036A MFG: FEB 2024 EXP: | $50.0K | 1 |
| MEDICINES AMIKACIN SULFATE INJECTION 500MG/2ML TILLOMED UK SN BATCH NO. ES240030A MFG FEB 2024 EXP JAN 2026 | $50.0K | 1 |
| MEDICINES AMIKACIN SULFATE INJECTION 500MG/2ML TILLOMED UK SN BATCH NO. ES240038A MFG FEB 2024 EXP JAN 2026 | $50.0K | 1 |
| AMIKACIN SULFATE INJ 500MG/2ML MA CA SN(NO.OF VIALS 30000) BATCH NO:ES240107A MFG:APR-2024 EXP:MAR 2027 | $50.0K | 1 |
| MEDICINES AMIKACIN SULFA INJ 500MG/2ML TILLO UK SN: BATCH NO. : ES250029B, MFG: Jan 2025 , EXP: Dec 2026 | $50.0K | 1 |
Emcure Pharmaceuticals Limited exports 14 distinct Amikacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMIKACIN SULFATE INJ 500MG/2ML MA CA SN with 4 shipments worth $161.9K.
Regulatory Requirements: Exporting Amikacin to Key Markets
What Emcure Pharmaceuticals Limited must comply with to export Amikacin to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Amikacin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | AJANTA PHARMA LIMITED | $1.4M | 28 | 1 | $50.0K |
| 7 | SCOTT EDIL PHARMACIA LIMITED | $875.1K | 108 | 15 | $8.1K |
| 4 | EMCURE PHARMACEUTICALS LIMITED ★ | $800.0K | 16 | 3 | $50.0K |
| 6 | BRAWN LABORATORIES LIMITED | $750.0K | 15 | 4 | $50.0K |
| 8 | LABORATE PHARMACEUTICALS INDIA LTD | $701.0K | 62 | 7 | $11.3K |
Emcure Pharmaceuticals Limited ranks #4 among 327 Indian Amikacin exporters. Average shipment value of $50.0K compared to the market average of $29.1K. The closest competitors by value are AJANTA PHARMA LIMITED and SCOTT EDIL PHARMACIA LIMITED.
Which Indian Ports Ship Amikacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 187 | 11.3% |
| SAHAR AIR | 181 | 10.9% |
| NHAVA SHEVA SEA (INNSA1) | 118 | 7.1% |
| JNPT/ NHAVA SHEVA SEA | 77 | 4.6% |
| MUNDRA SEA | 76 | 4.6% |
| JNPT | 73 | 4.4% |
| DELHI AIR CARGO ACC (INDEL4) | 57 | 3.4% |
| DELHI AIR | 56 | 3.4% |
What Other Advanced Antibiotics Products Does Emcure Pharmaceuticals Limited Export?
Emcure Pharmaceuticals Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Amikacin Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Amikacin, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Amikacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Amikacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 20 individual customs records matching Emcure Pharmaceuticals Limited exporting Amikacin, covering 14 formulations to 3 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 514+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Amikacin Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Amikacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Amikacin Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amikacin. For current shipment-level data, contact TransData Nexus.